≡ Search

logo - Farma Industria Ticino

  • Home
  • Members
  • News
  • Events
  • Contact
  • About us
  • Jobs
  • IT

Main activities

  • Licensing-In
  • Licensing-Out
  • Co-development
  • Trading
  • Drug Product CMO
  • Drug Substance CMO
  • Other CMO Activities

Other activities

  • Analytical Services
  • Cosmetics
  • Distribution
  • Feed Additives
  • Flavours and Fragrances
  • Medical Devices
  • Medical Food
  • Natural Products
  • Nutraceuticals
  • Pre-formulation

2012

Helsinn Grants Specialised Therapeutics Australia (STA) Rights to Anamorelin

22 October 2012

Helsinn Group, Switzerland announces a license agreement for Netupitant

25 September 2012

Helsinn grants to Dara exclusive u.s. commercial rights to Gelclair®

25 September 2012

Thorne Research, inc. and Helsinn Healthcare SA, announce Oncoqol™

25 September 2012

Cerbios Pharma and XSpray agree to establish a long-term partnership on the use of XSpray’s RightSizeTM technology

31 August 2012

Helsinn partners with the European school of oncology (ESO)

17 July 2012

Lipidor and Cerbios-Pharma have signed an agreement for the co- development of an innovative topical delivery system

13 June 2012

Cerbios appoints Andrea Tam as Director of Commercial Business Development

22 May 2012

Voluntary Climate Protection

16 March 2012

BAK - The economic portrait of Ticino’s life science sector

Progetto Talenti

Cultura e salute

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
Also on:
Linkedin
  • Education
  • Contact
  • Restricted area
  • About us

©2023 Farma Industria Ticino

Made by plastical

Loading...